Codes / ICD10CM / T46.1X1D

T46.1X1D Poisoning by calcium-channel blockers, accidental (unintentional), subsequent encounter

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Poisoning by calcium-channel blockers, accidental (unintentional), subsequent encounter

Summary

This code represents accidental (unintentional) poisoning by calcium-channel blockers during a subsequent encounter. Calcium-channel blockers are medications used to treat conditions like hypertension and angina by relaxing blood vessels and reducing heart rate. Accidental poisoning occurs when a person takes an excessive dose unintentionally, and the "subsequent encounter" modifier indicates care for the same condition after the acute phase or during recovery.

Causes

Accidental poisoning may result from taking more than the prescribed dose, misinterpreting dosing instructions, or inadvertently consuming the medication (e.g., by a child or someone unfamiliar with the drug). It can also occur due to product mix-ups or improper storage leading to unintended access. The subsequent encounter modifier applies when the patient is receiving ongoing care for the poisoning after the initial acute phase.

Risk Factors

  • Advanced age, which may increase susceptibility to dosing errors or confusion.
  • Polypharmacy (taking multiple medications), raising the risk of accidental overdose.
  • Cognitive impairment or memory issues affecting adherence to dosing regimens.
  • Lack of supervision in children or vulnerable adults.
  • Inadequate medication storage (e.g., leaving drugs accessible).

Symptoms

  • Hypotension (low blood pressure) and dizziness.
  • Bradycardia (slow heart rate) or arrhythmias.
  • Nausea, vomiting, or abdominal pain.
  • Lethargy, confusion, or altered mental status.
  • In severe cases, cardiac arrest or respiratory depression.

Diagnosis

Diagnosis involves clinical evaluation, including patient history (e.g., medication exposure, dosing errors) and physical examination. Laboratory tests may assess drug levels, electrolytes, and organ function (e.g., kidney or liver). Imaging or cardiac monitoring might be used to evaluate complications like arrhythmias or heart failure. The "subsequent encounter" context confirms ongoing care for the same poisoning episode.

Treatment Options

Treatment focuses on stabilizing the patient, managing symptoms, and supporting recovery. This may include monitoring vital signs, administering medications to reverse effects (e.g., calcium, vasopressors), and providing supportive care (e.g., IV fluids, oxygen). The approach depends on the severity of poisoning and any residual effects from the initial episode.

Prognosis and Follow-Up

Prognosis varies based on the dose ingested, time to treatment, and patient factors (e.g., age, comorbidities). Most patients recover with appropriate care, but severe cases may have long-term complications. Follow-up care ensures resolution of symptoms, addresses underlying causes (e.g., medication management), and prevents recurrence.

Complications

  • Prolonged hypotension or bradycardia.
  • Cardiac arrhythmias or heart failure.
  • Kidney or liver damage from toxin accumulation.
  • Neurological effects (e.g., confusion, seizures).
  • Respiratory depression in severe cases.

Lifestyle & Prevention

  • Store medications securely, out of reach of children or vulnerable individuals.
  • Use pill organizers or reminders to avoid dosing errors.
  • Review medication lists with healthcare providers to minimize interactions.
  • Educate patients and caregivers on proper dosing and storage.
  • Dispose of unused medications safely to prevent accidental access.

When to Seek Professional Help

Seek immediate medical attention if poisoning is suspected, especially with symptoms like severe dizziness, fainting, or difficulty breathing. For subsequent encounters, consult a healthcare provider if symptoms worsen, new issues arise, or follow-up care is needed.

Tips for Medical Coders

Use this code for accidental (unintentional) calcium-channel blocker poisoning during a subsequent encounter. Document the clinical context (e.g., ongoing care for the same episode) and confirm the accidental nature of the poisoning. Ensure the encounter is not the initial treatment phase, as that would use a different code. Verify the medication class (calcium-channel blockers) and exclude intentional or adverse effect scenarios.

Book a walkthrough

T46.1X1D policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.